StockWatch
·

SG Finserve Ltd

BSE: 539199

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
161.00
+18.3%+115.5%
Expenditure
81.62
+26.5%+125.0%
Net Profit
58.80
+9.5%+107.1%
OPM %
91.82%
-0.64pp-0.22pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-19.5830.4080.38130.36180.35Q3 FY19Q4 FY19Q1 FY20Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Guidance Beaten Early, But Leverage and Cost Pressure Temper the Cheer

supply chain financing · AUM beat · all-time PAT

Result verdictFollow-upQ2 FY2721 Oct 20266 minFinancial Services

Record profits, FY target beaten early

supply chain financing · all-time PAT · AUM acceleration

TranscriptDeep diveQ2 FY2721 Oct 20266 minFinancial Services

SG Finserve Q2 FY27: Consolidated PAT doubles YoY to ₹58.5 Cr, NPM eases to 36.5%

nbfc · loan book growth · margin compression

ResultsQ2 FY2716 Oct 20263 minFinancial Services
Latest
Board Meeting16 Oct, 2:02 pm

SG Finserve Q2 FY27: Consolidated PAT doubles YoY to ₹58.5 Cr, NPM eases to 36.5%

SG Finserve's Q2 FY27 (quarter ended September 30, 2026) consolidated PAT came in at ₹58.53 Cr, up 106.4% year-on-year from ₹28.40 Cr in Q2 FY26, on consolidated revenue of ₹160.94 Cr (+115.4% YoY). Standalone tells the same story at essentially the same scale — PAT ₹58.80 Cr, up 107.1% YoY on revenue of ₹160.94 Cr — with the gap between the two (under 0.5%) explained entirely by two newly consolidated, auditor-flagged-immaterial subsidiaries rather than any divergence in the core lending business. Sequentially, growth continued but decelerated as expected for a scaling book: standalone PAT rose 9.6% QoQ (₹53.68 Cr in Q1 FY27) on 18.2% QoQ revenue growth, versus the 27% QoQ PBT growth the company flagged in Q1 — a normal moderation, not a red flag, since YoY remains the primary read and that stayed strong. The quarter's story is operating leverage lagging a book that is scaling fast: standalone net profit margin eased to 36.54% from 39.43% last quarter and 38.01% a year ago, with finance costs of ₹68.22 Cr (NPM eased to 36.5%). consuming over 42% of total expenses as the loan book, funded increasingly through debt (debt-equity moved to 2.73x from 2.18x QoQ per the regulatory ratio disclosures), scaled alongside revenue. Gross and net NPAs remained nil for the quarter, so the margin dip is a funding-cost/mix effect on a fast-growing book, not a credit-quality issue — consistent with the zero-NPA watch item flagged pre-result. Against management's own FY27 guidance of ₹300 Cr PBT and a ₹5,500 Cr AUM target, the quarter is tracking ahead: H1 FY27 standalone PBT of ₹150.98 Cr is almost exactly half the full-year PBT target (on pace, with two quarters to go), while the loan book has already reached ₹5,694 Cr as of H1-end — past the full-year AUM target with Q3 and Q4 still ahead, confirming the 25-30% AUM CAGR ambition laid out last quarter. Against our pre-result preview's expectations, the print lands squarely in range: Q2 PBT of ₹79.38 Cr (standalone) / ₹79.11 Cr (consolidated) sits within the flagged ₹75-80 Cr band, and the loan book at ₹5,694 Cr is marginally below the ~₹5,750 Cr estimate but still represents a 16%+ sequential pace. Street coverage remains thin — no consensus PAT/EPS estimate exists per our pre-result check, only broker price targets (Arihant Capital BUY, target ₹646; Univest target ₹705 for 2026) — so this print cannot be graded against a numeric consensus, only against the company's own guidance, which it is meeting or beating. The board used the same meeting to approve a 15.5% stake (₹4.65 Cr) in Succession Technologies, an IT-services firm, explicitly to build in-house AI and digital capability for the company's supply-chain financing and digital-lending book, alongside a 24.5% related-party stake in SG Enterprise Solutions for shared group services and a ₹48 Cr GIFT City subsidiary investment plan — all incremental infrastructure bets rather than capital-structure changes, with management reiterating no equity raise is planned.

16 Oct 2026, 02:02 pm

Corporate Events

Board MeetingSGFIN
2026
16Oct

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingSGFIN
2026
14Jul

Board Meeting

A meeting of the Board of Directors is scheduled to be held …

BSE Filing ↗
Board MeetingSGFIN
2026
30Jun

Board Meeting

The 32nd Annual General Meeting was held to receive and adop…

BSE Filing ↗
Board MeetingSGFIN
2026
16Apr

Board Meeting

To consider and approve the audited financial results for th…

BSE Filing ↗
Board MeetingSGFIN
2026
16Feb

Board Meeting

modifications in terms and conditions of the non-convertible…

BSE Filing ↗
Board MeetingSGFIN
2025
8May

Board Meeting

Board Meeting Intimation, consider and approve audited finan…

BSE Filing ↗
Board MeetingSGFIN
2024
15Oct

Board Meeting

consider and approve the unaudited financial results of the …

BSE Filing ↗
Board MeetingSGFIN
2024
5Sep

Board Meeting

fund raising through preferential issue or any other method …

BSE Filing ↗
Board MeetingSGFIN
2024
10Jul

Board Meeting

Board Meeting

BSE Filing ↗
Board MeetingSGFIN
2024
28May

Board Meeting

consider and approve audited financial results of the Compan…

BSE Filing ↗